{
  "DOI": "10.1186/s40246-018-0150-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-018-0150-x",
  "alternative-id": [
    "150"
  ],
  "article-number": "20",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "21 December 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "23 March 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "11 April 2018"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Vural",
      "given": "Suleyman",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Simon",
      "given": "Richard",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-0950-0621",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Krushkal",
      "given": "Julia",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        4,
        11
      ]
    ],
    "date-time": "2018-04-11T13:01:40Z",
    "timestamp": 1523451700000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        10,
        31
      ]
    ],
    "date-time": "2020-10-31T14:22:01Z",
    "timestamp": 1604154121000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        1,
        31
      ]
    ],
    "date-time": "2024-01-31T13:49:49Z",
    "timestamp": 1706708989938
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2018,
        4,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            4,
            11
          ]
        ],
        "date-time": "2018-04-11T00:00:00Z",
        "timestamp": 1523404800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0150-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-018-0150-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-018-0150-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2018,
        4,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        4,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.2217/epi.14.35",
      "author": "DM Franchini",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "issue": "4",
      "journal-title": "Epigenomics",
      "key": "150_CR1",
      "unstructured": "Franchini DM, Petersen-Mahrt SK. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity. Epigenomics. 2014;6(4):427–43.",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.2736",
      "author": "KJ Kuong",
      "doi-asserted-by": "publisher",
      "first-page": "964",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "150_CR2",
      "unstructured": "Kuong KJ, Loeb LA. APOBEC3B mutagenesis in cancer. Nat Genet. 2013;45(9):964–5.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1146/annurev-pharmtox-010617-053021",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "journal-title": "Annu Rev Pharmacol Toxicol",
      "key": "150_CR3",
      "unstructured": "Lauschke VM, Barragan I, Ingelman-Sundberg M. Pharmacoepigenetics and toxicoepigenetics: novel mechanistic insights and therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2018;58:161–85.",
      "volume": "58",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cell.2011.03.022",
      "author": "JU Guo",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "issue": "3",
      "journal-title": "Cell",
      "key": "150_CR4",
      "unstructured": "Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011;145(3):423–34.",
      "volume": "145",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s13578-017-0156-4",
      "author": "J Zou",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Cell Biosci",
      "key": "150_CR5",
      "unstructured": "Zou J, Wang C, Ma X, Wang E, Peng G. APOBEC3B, a molecular driver of mutagenesis in human cancers. Cell Biosci. 2017;7:29.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ng.2702",
      "author": "SA Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "970",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "150_CR6",
      "unstructured": "Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45(9):970–6.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.3670",
      "author": "CD Middlebrooks",
      "doi-asserted-by": "publisher",
      "first-page": "1330",
      "issue": "11",
      "journal-title": "Nat Genet",
      "key": "150_CR7",
      "unstructured": "Middlebrooks CD, Banday AR, Matsuda K, Udquim KI, Onabajo OO, Paquin A, Figueroa JD, Zhu B, Koutros S, Kubo M, et al. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat Genet. 2016;48(11):1330–8.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13058-014-0498-3",
      "author": "RS Harris",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "Breast Cancer Res",
      "key": "150_CR8",
      "unstructured": "Harris RS. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer. Breast Cancer Res. 2015;17:8.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.18632/oncoscience.155",
      "author": "S Rebhandl",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "issue": "4",
      "journal-title": "Oncoscience",
      "key": "150_CR9",
      "unstructured": "Rebhandl S, Huemer M, Greil R, Geisberger R. AID/APOBEC deaminases and cancer. Oncoscience. 2015;2(4):320–33.",
      "volume": "2",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrc3816",
      "author": "SA Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "786",
      "issue": "12",
      "journal-title": "Nat Rev Cancer",
      "key": "150_CR10",
      "unstructured": "Roberts SA, Gordenin DA. Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer. 2014;14(12):786–800.",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature12477",
      "author": "LB Alexandrov",
      "doi-asserted-by": "publisher",
      "first-page": "415",
      "issue": "7463",
      "journal-title": "Nature",
      "key": "150_CR11",
      "unstructured": "Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–21.",
      "volume": "500",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.2701",
      "author": "MB Burns",
      "doi-asserted-by": "publisher",
      "first-page": "977",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "150_CR12",
      "unstructured": "Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet. 2013;45(9):977–83.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cell.2017.07.003",
      "author": "F Supek",
      "doi-asserted-by": "publisher",
      "first-page": "534",
      "issue": "3",
      "journal-title": "Cell",
      "key": "150_CR13",
      "unstructured": "Supek F, Lehner B. Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes. Cell. 2017;170(3):534–47. e23",
      "volume": "170",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrg3729",
      "author": "T Helleday",
      "doi-asserted-by": "publisher",
      "first-page": "585",
      "issue": "9",
      "journal-title": "Nat Rev Genet",
      "key": "150_CR14",
      "unstructured": "Helleday T, Eshtad S, Nik-Zainal S. Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet. 2014;15(9):585–98.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature21504",
      "author": "DA Fruman",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "issue": "7642",
      "journal-title": "Nature",
      "key": "150_CR15",
      "unstructured": "Fruman DA, O'Brien S. Cancer: a targeted treatment with off-target risks. Nature. 2017;542(7642):424–5.",
      "volume": "542",
      "year": "2017"
    },
    {
      "DOI": "10.1021/acs.chemrev.6b00296",
      "author": "SU Siriwardena",
      "doi-asserted-by": "publisher",
      "first-page": "12688",
      "issue": "20",
      "journal-title": "Chem Rev",
      "key": "150_CR16",
      "unstructured": "Siriwardena SU, Chen K, Bhagwat AS. Functions and malfunctions of mammalian DNA-cytosine deaminases: the known knowns and the known unknowns. Chem Rev. 2016;116(20):12688–710.",
      "volume": "116",
      "year": "2016"
    },
    {
      "DOI": "10.1093/hmg/dds513",
      "author": "T Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "1262",
      "issue": "6",
      "journal-title": "Hum Mol Genet",
      "key": "150_CR17",
      "unstructured": "Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, Zhai K, Bi X, Zhao H, Xu J, et al. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum Mol Genet. 2013;22(6):1262–9.",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1126/sciadv.1601737",
      "author": "EK Law",
      "doi-asserted-by": "publisher",
      "first-page": "e1601737",
      "issue": "10",
      "journal-title": "Sci Adv",
      "key": "150_CR18",
      "unstructured": "Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, Temiz NA, Vogel RI, Meijer-van Gelder ME, Sweep FC, et al. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Sci Adv. 2016;2(10):e1601737.",
      "volume": "2",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.3378",
      "author": "K Chan",
      "doi-asserted-by": "publisher",
      "first-page": "1067",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "150_CR19",
      "unstructured": "Chan K, Roberts SA, Klimczak LJ, Sterling JF, Saini N, Malc EP, Kim J, Kwiatkowski DJ, Fargo DC, Mieczkowski PA, et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 2015;47(9):1067–72.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.7554/eLife.00534",
      "author": "BJ Taylor",
      "doi-asserted-by": "publisher",
      "first-page": "e00534",
      "journal-title": "elife",
      "key": "150_CR20",
      "unstructured": "Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, Campbell PJ, Rada C, Stratton MR, Neuberger MS. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. elife. 2013;2:e00534.",
      "volume": "2",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature11881",
      "author": "MB Burns",
      "doi-asserted-by": "publisher",
      "first-page": "366",
      "issue": "7437",
      "journal-title": "Nature",
      "key": "150_CR21",
      "unstructured": "Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013;494(7437):366–70.",
      "volume": "494",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cell.2012.04.024",
      "author": "S Nik-Zainal",
      "doi-asserted-by": "publisher",
      "first-page": "979",
      "issue": "5",
      "journal-title": "Cell",
      "key": "150_CR22",
      "unstructured": "Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149(5):979–93.",
      "volume": "149",
      "year": "2012"
    },
    {
      "DOI": "10.1038/embor.2011.46",
      "author": "S Landry",
      "doi-asserted-by": "publisher",
      "first-page": "444",
      "issue": "5",
      "journal-title": "EMBO Rep",
      "key": "150_CR23",
      "unstructured": "Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep. 2011;12(5):444–50.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1009687108",
      "author": "R Suspene",
      "doi-asserted-by": "publisher",
      "first-page": "4858",
      "issue": "12",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "150_CR24",
      "unstructured": "Suspene R, Aynaud MM, Guetard D, Henry M, Eckhoff G, Marchio A, Pineau P, Dejean A, Vartanian JP, Wain-Hobson S. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A. 2011;108(12):4858–63.",
      "volume": "108",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.str.2015.03.016",
      "author": "MF Bohn",
      "doi-asserted-by": "publisher",
      "first-page": "903",
      "issue": "5",
      "journal-title": "Structure",
      "key": "150_CR25",
      "unstructured": "Bohn MF, Shandilya SMD, Silvas TV, Nalivaika EA, Kouno T, Kelch BA, Ryder SP, Kurt-Yilmaz N, Somasundaran M, Schiffer CA. The ssDNA Mutator APOBEC3A is regulated by cooperative dimerization. Structure. 2015;23(5):903–11.",
      "volume": "23",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.tibs.2016.05.001",
      "author": "JD Salter",
      "doi-asserted-by": "publisher",
      "first-page": "578",
      "issue": "7",
      "journal-title": "Trends Biochem Sci",
      "key": "150_CR26",
      "unstructured": "Salter JD, Bennett RP, Smith HC. The APOBEC protein family: united by structure, divergent in function. Trends Biochem Sci. 2016;41(7):578–94.",
      "volume": "41",
      "year": "2016"
    },
    {
      "DOI": "10.1002/ijc.21570",
      "author": "B Gyorffy",
      "doi-asserted-by": "publisher",
      "first-page": "1699",
      "issue": "7",
      "journal-title": "Int J Cancer",
      "key": "150_CR27",
      "unstructured": "Gyorffy B, Surowiak P, Kiesslich O, Denkert C, Schafer R, Dietel M, Lage H. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006;118(7):1699–712.",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1038/bjc.2017.133",
      "doi-asserted-by": "crossref",
      "key": "150_CR28",
      "unstructured": "Nikkila J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG, Serebrenik AA, et al. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. Br J Cancer. 2017;117(1):113-23."
    },
    {
      "DOI": "10.1186/s13059-016-1042-9",
      "author": "N Kanu",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "150_CR29",
      "unstructured": "Kanu N, Cerone MA, Goh G, Zalmas LP, Bartkova J, Dietzen M, McGranahan N, Rogers R, Law EK, Gromova I, et al. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer. Genome Biol. 2016;17(1):185.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2016.06.017",
      "author": "F Iorio",
      "doi-asserted-by": "publisher",
      "first-page": "740",
      "issue": "3",
      "journal-title": "Cell",
      "key": "150_CR30",
      "unstructured": "Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Goncalves E, Barthorpe S, Lightfoot H, et al. A landscape of pharmacogenomic interactions in cancer. Cell. 2016;166(3):740–54.",
      "volume": "166",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13059-016-1069-y",
      "author": "DW Cescon",
      "doi-asserted-by": "publisher",
      "first-page": "202",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "150_CR31",
      "unstructured": "Cescon DW, Haibe-Kains B. DNA replication stress: a source of APOBEC3B expression in breast cancer. Genome Biol. 2016;17(1):202.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.18632/oncotarget.2636",
      "author": "CE Waters",
      "doi-asserted-by": "publisher",
      "first-page": "3409",
      "issue": "5",
      "journal-title": "Oncotarget",
      "key": "150_CR32",
      "unstructured": "Waters CE, Saldivar JC, Amin ZA, Schrock MS, Huebner K. FHIT loss-induced DNA damage creates optimal APOBEC substrates: insights into APOBEC-mediated mutagenesis. Oncotarget. 2015;6(5):3409–19.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature11003",
      "author": "J Barretina",
      "doi-asserted-by": "publisher",
      "first-page": "603",
      "issue": "7391",
      "journal-title": "Nature",
      "key": "150_CR33",
      "unstructured": "Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603–7.",
      "volume": "483",
      "year": "2012"
    },
    {
      "key": "150_CR34",
      "unstructured": "CCLE Cancer Cell Line Encyclopedia. http://www.broadinstitute.org/ccle . Accessed 22 Sept 2016."
    },
    {
      "DOI": "10.1038/nature11005",
      "author": "MJ Garnett",
      "doi-asserted-by": "publisher",
      "first-page": "570",
      "issue": "7391",
      "journal-title": "Nature",
      "key": "150_CR35",
      "unstructured": "Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, Greninger P, Thompson IR, Luo X, Soares J, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570–5.",
      "volume": "483",
      "year": "2012"
    },
    {
      "key": "150_CR36",
      "unstructured": "Genomics of Drug Sensitivity in Cancer. http://www.cancerrxgene.org/ . Accessed 22 Sept 2016."
    },
    {
      "key": "150_CR37",
      "unstructured": "National Cancer Institute GDC Legacy Archive. https://portal.gdc.cancer.gov/legacy-archive . Accessed 10 Mar 2018."
    },
    {
      "DOI": "10.1002/humu.23308",
      "author": "LC Chang",
      "doi-asserted-by": "publisher",
      "first-page": "1449",
      "issue": "11",
      "journal-title": "Hum Mutat",
      "key": "150_CR38",
      "unstructured": "Chang LC, Vural S, Sonkin D. Detection of homozygous deletions in tumor-suppressor genes ranging from dozen to hundreds nucleotides in cancer models. Hum Mutat. 2017;38(11):1449–53.",
      "volume": "38",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ng.806",
      "author": "MA DePristo",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "150_CR39",
      "unstructured": "DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491–8.",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1101/gr.107524.110",
      "author": "A McKenna",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "issue": "9",
      "journal-title": "Genome Res",
      "key": "150_CR40",
      "unstructured": "McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1002/0471250953.bi1110s43",
      "doi-asserted-by": "crossref",
      "key": "150_CR41",
      "unstructured": "Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, Jordan T, Shakir K, Roazen D, Thibault J, et al. From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;11(1110):11.10.1–11.10.33.﻿"
    },
    {
      "DOI": "10.1101/gr.129684.111",
      "author": "DC Koboldt",
      "doi-asserted-by": "publisher",
      "first-page": "568",
      "issue": "3",
      "journal-title": "Genome Res",
      "key": "150_CR42",
      "unstructured": "Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568–76.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "A Auton",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "issue": "7571",
      "journal-title": "Nature",
      "key": "150_CR43",
      "unstructured": "Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.celrep.2012.12.008",
      "author": "LB Alexandrov",
      "doi-asserted-by": "publisher",
      "first-page": "246",
      "issue": "1",
      "journal-title": "Cell Rep",
      "key": "150_CR44",
      "unstructured": "Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013;3(1):246–59.",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1093/biostatistics/4.2.249",
      "author": "RA Irizarry",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "issue": "2",
      "journal-title": "Biostatistics",
      "key": "150_CR45",
      "unstructured": "Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–64.",
      "volume": "4",
      "year": "2003"
    },
    {
      "DOI": "10.7171/jbt.18-2902-002",
      "doi-asserted-by": "crossref",
      "key": "150_CR46",
      "unstructured": "The Cellosaurus: a cell line knowledge resource. http://web.expasy.org/cellosaurus/ . Accessed 25 Apr 2017."
    },
    {
      "DOI": "10.1038/nature15736",
      "doi-asserted-by": "crossref",
      "key": "150_CR47",
      "unstructured": "Cancer Cell Line Encyclopedia C, Genomics of Drug Sensitivity in Cancer C: Pharmacogenomic agreement between two cancer cell line data sets. Nature 2015;528(7580):84–87."
    },
    {
      "DOI": "10.12688/f1000research.9611.1",
      "author": "Z Safikhani",
      "doi-asserted-by": "publisher",
      "first-page": "2333",
      "journal-title": "F1000Res",
      "key": "150_CR48",
      "unstructured": "Safikhani Z, Smirnov P, Freeman M, El-Hachem N, She A, Rene Q, Goldenberg A, Birkbak NJ, Hatzis C, Shi L, et al. Revisiting inconsistency in large pharmacogenomic studies. F1000Res. 2016;5:2333.",
      "volume": "5",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature17987",
      "author": "PM Haverty",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "issue": "7603",
      "journal-title": "Nature",
      "key": "150_CR49",
      "unstructured": "Haverty PM, Lin E, Tan J, Yu Y, Lam B, Lianoglou S, Neve RM, Martin S, Settleman J, Yauch RL, et al. Reproducible pharmacogenomic profiling of cancer cell line panels. Nature. 2016;533(7603):333–7.",
      "volume": "533",
      "year": "2016"
    },
    {
      "author": "Y Benjamini",
      "first-page": "289",
      "journal-title": "J R Statist Soc",
      "key": "150_CR50",
      "unstructured": "Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc. 1995;B57:289–300.",
      "volume": "B57",
      "year": "1995"
    },
    {
      "DOI": "10.1172/JCI45014",
      "author": "BD Lehmann",
      "doi-asserted-by": "publisher",
      "first-page": "2750",
      "issue": "7",
      "journal-title": "J Clin Invest",
      "key": "150_CR51",
      "unstructured": "Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.",
      "volume": "121",
      "year": "2011"
    },
    {
      "DOI": "10.1038/onc.2015.487",
      "author": "SJ Conley",
      "doi-asserted-by": "publisher",
      "first-page": "4225",
      "issue": "32",
      "journal-title": "Oncogene",
      "key": "150_CR52",
      "unstructured": "Conley SJ, Bosco EE, Tice DA, Hollingsworth RE, Herbst R, Xiao Z. HER2 drives Mucin-like 1 to control proliferation in breast cancer cells. Oncogene. 2016;35(32):4225–34.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ccr.2006.10.008",
      "author": "RM Neve",
      "doi-asserted-by": "publisher",
      "first-page": "515",
      "issue": "6",
      "journal-title": "Cancer Cell",
      "key": "150_CR53",
      "unstructured": "Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10(6):515–27.",
      "volume": "10",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0006146",
      "author": "J Kao",
      "doi-asserted-by": "publisher",
      "first-page": "e6146",
      "issue": "7",
      "journal-title": "PLoS One",
      "key": "150_CR54",
      "unstructured": "Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 2009;4(7):e6146.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2015.62.1086",
      "author": "DN Hayes",
      "doi-asserted-by": "publisher",
      "first-page": "3227",
      "issue": "29",
      "journal-title": "J Clin Oncol",
      "key": "150_CR55",
      "unstructured": "Hayes DN, Van Waes C, Seiwert TY. Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J Clin Oncol. 2015;33(29):3227–34.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.molcel.2012.03.030",
      "author": "SA Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "issue": "4",
      "journal-title": "Mol Cell",
      "key": "150_CR56",
      "unstructured": "Roberts SA, Sterling J, Thompson C, Harris S, Mav D, Shah R, Klimczak LJ, Kryukov GV, Malc E, Mieczkowski PA, et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol Cell. 2012;46(4):424–35.",
      "volume": "46",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-14-1215",
      "author": "J Kim",
      "doi-asserted-by": "publisher",
      "first-page": "4514",
      "issue": "20",
      "journal-title": "Clin Cancer Res",
      "key": "150_CR57",
      "unstructured": "Kim J, Akbani R, Creighton CJ, Lerner SP, Weinstein JN, Getz G, Kwiatkowski DJ. Invasive bladder cancer: genomic insights and therapeutic promise. Clin Cancer Res. 2015;21(20):4514–24.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature22071",
      "author": "NK Hayward",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "issue": "7653",
      "journal-title": "Nature",
      "key": "150_CR58",
      "unstructured": "Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175–80.",
      "volume": "545",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrclinonc.2016.122",
      "author": "S Manier",
      "doi-asserted-by": "publisher",
      "first-page": "100",
      "issue": "2",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "150_CR59",
      "unstructured": "Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2017;14(2):100–13.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ncomms7997",
      "author": "BA Walker",
      "doi-asserted-by": "publisher",
      "first-page": "6997",
      "journal-title": "Nat Commun",
      "key": "150_CR60",
      "unstructured": "Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, Proszek PZ, Melchor L, Pawlyn C, Kaiser MF, et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015;6:6997.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature17676",
      "author": "S Nik-Zainal",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "issue": "7605",
      "journal-title": "Nature",
      "key": "150_CR61",
      "unstructured": "Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47–54.",
      "volume": "534",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pmed.1002193",
      "author": "T Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "e1002193",
      "issue": "12",
      "journal-title": "PLoS Med",
      "key": "150_CR62",
      "unstructured": "Jiang T, Shi W, Wali VB, Pongor LS, Li C, Lau R, Gyorffy B, Lifton RP, Symmans WF, Pusztai L, et al. Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis. PLoS Med. 2016;13(12):e1002193.",
      "volume": "13",
      "year": "2016"
    },
    {
      "DOI": "10.1158/2159-8290.CD-15-0344",
      "author": "C Swanton",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "issue": "7",
      "journal-title": "Cancer Discov",
      "key": "150_CR63",
      "unstructured": "Swanton C, McGranahan N, Starrett GJ, Harris RS. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 2015;5(7):704–12.",
      "volume": "5",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature12965",
      "author": "JN Weinstein",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "issue": "7492",
      "journal-title": "Nature",
      "key": "150_CR64",
      "unstructured": "Weinstein JN, Akbani R, Broom BM, Wang W, Verhaak RGW, McConkey D, Lerner S, Morgan M, Creighton CJ, Smith C, et al. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315–22.",
      "volume": "507",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature12213",
      "author": "MS Lawrence",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "issue": "7457",
      "journal-title": "Nature",
      "key": "150_CR65",
      "unstructured": "Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214–8.",
      "volume": "499",
      "year": "2013"
    },
    {
      "DOI": "10.1101/cshperspect.a012708",
      "author": "JE Sale",
      "doi-asserted-by": "publisher",
      "first-page": "a012708",
      "issue": "3",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "150_CR66",
      "unstructured": "Sale JE. Translesion DNA synthesis and mutagenesis in eukaryotes. Cold Spring Harb Perspect Biol. 2013;5(3):a012708.",
      "volume": "5",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fimmu.2014.00642",
      "author": "PM Dominguez",
      "doi-asserted-by": "publisher",
      "first-page": "642",
      "journal-title": "Front Immunol",
      "key": "150_CR67",
      "unstructured": "Dominguez PM, Shaknovich R. Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesis. Front Immunol. 2014;5:642.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1053/j.gastro.2016.09.008",
      "author": "Q Gao",
      "doi-asserted-by": "publisher",
      "first-page": "232",
      "issue": "1",
      "journal-title": "Gastroenterology",
      "key": "150_CR68",
      "unstructured": "Gao Q, Wang ZC, Duan M, Lin YH, Zhou XY, Worthley DL, Wang XY, Niu G, Xia Y, Deng M, et al. Cell culture system for analysis of genetic heterogeneity within hepatocellular carcinomas and response to pharmacologic agents. Gastroenterology. 2017;152(1):232–42. e4",
      "volume": "152",
      "year": "2017"
    },
    {
      "author": "PF Wu",
      "first-page": "1521",
      "issue": "3",
      "journal-title": "Anticancer Res",
      "key": "150_CR69",
      "unstructured": "Wu PF, Chen YS, Kuo TY, Lin HH, Liu CW, Chang LC. APOBEC3B: a potential factor suppressing growth of human hepatocellular carcinoma cells. Anticancer Res. 2015;35(3):1521–7.",
      "volume": "35",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.804",
      "author": "Y Totoki",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "150_CR70",
      "unstructured": "Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, Ishikawa S, Tsutsumi S, Sonoda K, Totsuka H, Shirakihara T, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011;43(5):464–9.",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.ppat.1003361",
      "author": "K Kitamura",
      "doi-asserted-by": "publisher",
      "first-page": "e1003361",
      "issue": "5",
      "journal-title": "PLoS Pathog",
      "key": "150_CR71",
      "unstructured": "Kitamura K, Wang Z, Chowdhury S, Simadu M, Koura M, Muramatsu M. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA. PLoS Pathog. 2013;9(5):e1003361.",
      "volume": "9",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0157708",
      "author": "X Luo",
      "doi-asserted-by": "publisher",
      "first-page": "e0157708",
      "issue": "6",
      "journal-title": "PLoS One",
      "key": "150_CR72",
      "unstructured": "Luo X, Huang Y, Chen Y, Tu Z, Hu J, Tavis JE, Huang A, Hu Y. Association of hepatitis B virus covalently closed circular DNA and human APOBEC3B in hepatitis B virus-related hepatocellular carcinoma. PLoS One. 2016;11(6):e0157708.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ng.2291",
      "author": "A Fujimoto",
      "doi-asserted-by": "publisher",
      "first-page": "760",
      "issue": "7",
      "journal-title": "Nat Genet",
      "key": "150_CR73",
      "unstructured": "Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012;44(7):760–4.",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.3126",
      "author": "Y Totoki",
      "doi-asserted-by": "publisher",
      "first-page": "1267",
      "issue": "12",
      "journal-title": "Nat Genet",
      "key": "150_CR74",
      "unstructured": "Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014;46(12):1267–73.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1074/jbc.M113.504175",
      "author": "P Pham",
      "doi-asserted-by": "publisher",
      "first-page": "29294",
      "issue": "41",
      "journal-title": "J Biol Chem",
      "key": "150_CR75",
      "unstructured": "Pham P, Landolph A, Mendez C, Li N, Goodman MF. A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer. J Biol Chem. 2013;288(41):29294–304.",
      "volume": "288",
      "year": "2013"
    },
    {
      "DOI": "10.1038/onc.2015.126",
      "author": "PL Garcia",
      "doi-asserted-by": "publisher",
      "first-page": "833",
      "issue": "7",
      "journal-title": "Oncogene",
      "key": "150_CR76",
      "unstructured": "Garcia PL, Miller AL, Kreitzburg KM, Council LN, Gamblin TL, Christein JD, Heslin MJ, Arnoletti JP, Richardson JH, Chen D, et al. The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene. 2016;35(7):833–45.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nm.3952",
      "author": "PK Mazur",
      "doi-asserted-by": "publisher",
      "first-page": "1163",
      "issue": "10",
      "journal-title": "Nat Med",
      "key": "150_CR77",
      "unstructured": "Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sanchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21(10):1163–71.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.canlet.2017.02.021",
      "author": "AS Leal",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Cancer Lett",
      "key": "150_CR78",
      "unstructured": "Leal AS, Williams CR, Royce DB, Pioli PA, Sporn MB, Liby KT. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer Lett. 2017;394:76–87.",
      "volume": "394",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-0589",
      "author": "Z Tao",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "150_CR79",
      "unstructured": "Tao Z, Le Blanc JM, Wang C, Zhan T, Zhuang H, Wang P, Yuan Z, Lu B. Coadministration of trametinib and palbociclib radiosensitizes KRAS-mutant non-small cell lung cancers in vitro and in vivo. Clin Cancer Res. 2016;22(1):122–33.",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nrclinonc.2014.83",
      "author": "Y Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "issue": "7",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "150_CR80",
      "unstructured": "Zhao Y, Adjei AA. The clinical development of MEK inhibitors. Nat Rev Clin Oncol. 2014;11(7):385–400.",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.yexcr.2015.03.019",
      "author": "N Ishida",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "issue": "2",
      "journal-title": "Exp Cell Res",
      "key": "150_CR81",
      "unstructured": "Ishida N, Fukazawa T, Maeda Y, Yamatsuji T, Kato K, Matsumoto K, Shimo T, Takigawa N, Whitsett JA, Naomoto Y. A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor. Exp Cell Res. 2015;335(2):197–206.",
      "volume": "335",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.bbrc.2012.02.158",
      "author": "X Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "issue": "2",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "150_CR82",
      "unstructured": "Zhou X, Yang XY, Popescu NC. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. Biochem Biophys Res Commun. 2012;420(2):325–30.",
      "volume": "420",
      "year": "2012"
    },
    {
      "author": "AA Adjei",
      "edition": "4",
      "first-page": "739",
      "key": "150_CR83",
      "unstructured": "Adjei AA. Other signal transduction agents. In: Pass HI, Carbone DP, Johnson DH, MD JDM, Scagliotti GV, III ATT, editors. Principles and practice of lung cancer: the official reference text of the International Association for the Study of Lung Cancer (IASLC). 4th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams \u0026 Wilkins; 2010. p. 739–52.",
      "volume-title": "Principles and practice of lung cancer: the official reference text of the International Association for the Study of Lung Cancer (IASLC)",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1756-8722-6-27",
      "author": "A Akinleye",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "J Hematol Oncol",
      "key": "150_CR84",
      "unstructured": "Akinleye A, Furqan M, Mukhi N, Ravella P, Liu D. MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013;6:27.",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-09-0683",
      "author": "N Gaspar",
      "doi-asserted-by": "publisher",
      "first-page": "1219",
      "issue": "5",
      "journal-title": "Mol Cancer Ther",
      "key": "150_CR85",
      "unstructured": "Gaspar N, Sharp SY, Eccles SA, Gowan S, Popov S, Jones C, Pearson A, Vassal G, Workman P. Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma. Mol Cancer Ther. 2010;9(5):1219–33.",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ncomms11383",
      "author": "S Morganella",
      "doi-asserted-by": "publisher",
      "first-page": "11383",
      "journal-title": "Nat Commun",
      "key": "150_CR86",
      "unstructured": "Morganella S, Alexandrov LB, Glodzik D, Zou X, Davies H, Staaf J, Sieuwerts AM, Brinkman AB, Martin S, Ramakrishna M, et al. The topography of mutational processes in breast cancer genomes. Nat Commun. 2016;7:11383.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.18632/oncotarget.8999",
      "author": "P Yang",
      "doi-asserted-by": "crossref",
      "first-page": "32652",
      "issue": "22",
      "journal-title": "Oncotarget",
      "key": "150_CR87",
      "unstructured": "Yang P, Chen W, Li X, Eilers G, He Q, Liu L, Wu Y, Wu Y, Yu W, Fletcher JA, et al. Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3. Oncotarget. 2016;7(22):32652–63.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1200/JCO.2013.49.8899",
      "author": "C Arce-Salinas",
      "doi-asserted-by": "publisher",
      "first-page": "e21",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "150_CR88",
      "unstructured": "Arce-Salinas C, Riesco-Martinez MC, Hanna W, Bedard P, Warner E. Complete response of metastatic androgen receptor-positive breast cancer to bicalutamide: case report and review of the literature. J Clin Oncol. 2016;34(4):e21–4.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.breast.2015.07.008",
      "author": "A Prat",
      "doi-asserted-by": "publisher",
      "first-page": "S26",
      "issue": "Suppl 2",
      "journal-title": "Breast",
      "key": "150_CR89",
      "unstructured": "Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, Diez M, Viladot M, Arance A, Munoz M. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26–35.",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ejmech.2016.09.049",
      "author": "V Asati",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "journal-title": "Eur J Med Chem",
      "key": "150_CR90",
      "unstructured": "Asati V, Mahapatra DK, Bharti SK. K-Ras and its inhibitors towards personalized cancer treatment: pharmacological and structural perspectives. Eur J Med Chem. 2017;125:299–314.",
      "volume": "125",
      "year": "2017"
    },
    {
      "DOI": "10.4103/0976-500X.107628",
      "author": "S Sandhiya",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "issue": "1",
      "journal-title": "J Pharmacol Pharmacother",
      "key": "150_CR91",
      "unstructured": "Sandhiya S, Melvin G, Kumar SS, Dkhar SA. The dawn of hedgehog inhibitors: Vismodegib. J Pharmacol Pharmacother. 2013;4(1):4–7.",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.1424869112",
      "author": "DW Cescon",
      "doi-asserted-by": "publisher",
      "first-page": "2841",
      "issue": "9",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "150_CR92",
      "unstructured": "Cescon DW, Haibe-Kains B, Mak TW. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation. Proc Natl Acad Sci U S A. 2015;112(9):2841–6.",
      "volume": "112",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jmoldx.2012.01.007",
      "author": "DN Kernagis",
      "doi-asserted-by": "publisher",
      "first-page": "214",
      "issue": "3",
      "journal-title": "J Mol Diagn",
      "key": "150_CR93",
      "unstructured": "Kernagis DN, Hall AH, Datto MB. Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival. J Mol Diagn. 2012;14(3):214–22.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2105-11-276",
      "author": "B Hellwig",
      "doi-asserted-by": "publisher",
      "first-page": "276",
      "journal-title": "BMC Bioinformatics.",
      "key": "150_CR94",
      "unstructured": "Hellwig B, Hengstler JG, Schmidt M, Gehrmann MC, Schormann W, Rahnenfuhrer J. Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes. BMC Bioinformatics. 2010;11:276.",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2105-7-49",
      "author": "JN McClintick",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "BMC Bioinformatics",
      "key": "150_CR95",
      "unstructured": "McClintick JN, Edenberg HJ. Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics. 2006;7:49.",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0087679",
      "author": "D Ebrahimi",
      "doi-asserted-by": "publisher",
      "first-page": "e87679",
      "issue": "1",
      "journal-title": "PLoS One",
      "key": "150_CR96",
      "unstructured": "Ebrahimi D, Alinejad-Rokny H, Davenport MP. Insights into the motif preference of APOBEC3 enzymes. PLoS One. 2014;9(1):e87679.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1038/srep27702",
      "author": "SA Mullane",
      "doi-asserted-by": "publisher",
      "first-page": "27702",
      "journal-title": "Sci Rep",
      "key": "150_CR97",
      "unstructured": "Mullane SA, Werner L, Rosenberg J, Signoretti S, Callea M, Choueiri TK, Freeman GJ, Bellmunt J. Correlation of Apobec Mrna expression with overall survival and pd-l1 expression in urothelial carcinoma. Sci Rep. 2016;6:27702.",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-2910",
      "author": "B Leonard",
      "doi-asserted-by": "publisher",
      "first-page": "4746",
      "issue": "18",
      "journal-title": "Clin Cancer Res",
      "key": "150_CR98",
      "unstructured": "Leonard B, Starrett GJ, Maurer MJ, Oberg AL, Van Bockstal M, Van Dorpe J, De Wever O, Helleman J, Sieuwerts AM, Berns EM, et al. APOBEC3G expression correlates with T-cell infiltration and improved clinical outcomes in high-grade serous ovarian carcinoma. Clin Cancer Res. 2016;22(18):4746–55.",
      "volume": "22",
      "year": "2016"
    },
    {
      "author": "H Lan",
      "first-page": "665",
      "issue": "3",
      "journal-title": "Int J Clin Exp Med",
      "key": "150_CR99",
      "unstructured": "Lan H, Jin K, Gan M, Wen S, Bi T, Zhou S, Zhu N, Teng L, Yu W. APOBEC3G expression is correlated with poor prognosis in colon carcinoma patients with hepatic metastasis. Int J Clin Exp Med. 2014;7(3):665–72.",
      "volume": "7",
      "year": "2014"
    },
    {
      "DOI": "10.1186/bcr2419",
      "author": "RS Finn",
      "doi-asserted-by": "publisher",
      "first-page": "R77",
      "issue": "5",
      "journal-title": "Breast Cancer Res",
      "key": "150_CR100",
      "unstructured": "Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, Ginther C, Atefi M, Chen I, Fowst C, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77.",
      "volume": "11",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-14-0947",
      "author": "D Sarker",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "150_CR101",
      "unstructured": "Sarker D, Ang JE, Baird R, Kristeleit R, Shah K, Moreno V, Clarke PA, Raynaud FI, Levy G, Ware JA, et al. First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors. Clin Cancer Res. 2015;21(1):77–86.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1074/jbc.M703571200",
      "author": "A Shutes",
      "doi-asserted-by": "publisher",
      "first-page": "35666",
      "issue": "49",
      "journal-title": "J Biol Chem",
      "key": "150_CR102",
      "unstructured": "Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F, Der CJ. Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem. 2007;282(49):35666–78.",
      "volume": "282",
      "year": "2007"
    },
    {
      "DOI": "10.3892/br.2013.91",
      "author": "K Umene",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "issue": "3",
      "journal-title": "Biomed Rep",
      "key": "150_CR103",
      "unstructured": "Umene K, Banno K, Kisu I, Yanokura M, Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, et al. Aurora kinase inhibitors: potential molecular-targeted drugs for gynecologic malignant tumors. Biomed Rep. 2013;1(3):335–40.",
      "volume": "1",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2010.08.008",
      "author": "Q Yang",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "issue": "3",
      "journal-title": "Cancer Cell",
      "key": "150_CR104",
      "unstructured": "Yang Q, Deng X, Lu B, Cameron M, Fearns C, Patricelli MP, Yates JR 3rd, Gray NS, Lee JD. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010;18(3):258–67.",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-10-0581",
      "author": "H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "issue": "1",
      "journal-title": "Mol Cancer Ther",
      "key": "150_CR105",
      "unstructured": "Wang H, Ma X, Ren S, Buolamwini JK, Yan C. A small-molecule inhibitor of MDMX activates p53 and induces apoptosis. Mol Cancer Ther. 2011;10(1):69–79.",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-05-0410",
      "author": "DH Albert",
      "doi-asserted-by": "publisher",
      "first-page": "995",
      "issue": "4",
      "journal-title": "Mol Cancer Ther",
      "key": "150_CR106",
      "unstructured": "Albert DH, Tapang P, Magoc TJ, Pease LJ, Reuter DR, Wei RQ, Li J, Guo J, Bousquet PF, Ghoreishi-Haack NS, et al. Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor. Mol Cancer Ther. 2006;5(4):995–1006.",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0968-0896(00)00301-1",
      "author": "VS Li",
      "doi-asserted-by": "publisher",
      "first-page": "863",
      "issue": "4",
      "journal-title": "Bioorg Med Chem",
      "key": "150_CR107",
      "unstructured": "Li VS, Tang MS, Kohn H. The effect of C(5) cytosine methylation at CpG sequences on mitomycin-DNA bonding profiles. Bioorg Med Chem. 2001;9(4):863–73.",
      "volume": "9",
      "year": "2001"
    }
  ],
  "reference-count": 107,
  "references-count": 107,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-018-0150-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "12"
}